Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Gilead Sciences Inc (NASDAQ:GILD)

85.60
Delayed Data
As of May 04
 -1.57 / -1.80%
Today’s Change
81.89
Today|||52-Week Range
123.37
-15.41%
Year-to-Date

Today’s Trading

Previous close87.17
Today’s open86.66
Day’s range85.41 - 86.99
Volume12,187,807
Average volume (3 months)12,178,469
Market cap$118.1B
Dividend yield2.20%
Data as of 3:59pm ET, 05/04/2016

Growth & Valuation

Earnings growth (last year)+62.04%
Earnings growth (this year)-3.80%
Earnings growth (next 5 years)+2.50%
Revenue growth (last year)+28.71%
P/E ratio7.2
Price/Sales4.80
Price/Book6.69

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-2.17-1.39%
BIIBBiogen-10.59-3.87%
BXLTBaxalta Inc-0.91-2.15%
BAXBaxter International...+0.73+1.64%
Data as of 4:01pm ET, 05/04/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$3.08
Annual revenue (last year)$32.0B
Annual profit (last year)$18.1B
Net profit margin56.52%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John F. Milligan
Chief Financial Officer &
Executive Vice President
Robin L. Washington
Corporate headquarters
Foster City, California

Forecasts

Partner Offers

Search for Jobs